Ligand-Induced Repression of the Glucocorticoid Receptor Gene Is Mediated by an NCoR1 Repression Complex Formed by Long-Range Chromatin Interactions with Intragenic Glucocorticoid Response Elements
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most potent and effective agents for treating inflammatory diseases and hematological cancers. However, subpopulations of patients are often resistant to steroid therapy, and determining the molecular mechanisms that contribute to glucocorticoid resistance is thus critical to addressing this clinical problem affecting patients with chronic inflammatory disorders. Since the cellular level of the glucocorticoid receptor (GR) is a critical determinant of glucocorticoid sensitivity and resistance, we investigated the molecular mechanisms mediating repression of glucocorticoid receptor gene expression. We show here that glucocorticoid-induced repression of GR gene expression is mediated by inhibition of transcription initiation. This process is orchestrated by the recruitment of agonist-bound GR to exon 6, followed by the assembly of a GR-NCoR1-histone deacetylase 3-containing repression complex at the transcriptional start site of the GR gene. A functional negative glucocorticoid response element (nGRE) in exon 6 of the GR gene and a long-range interaction occurring between this intragenic response element and the transcription start site appear to be instrumental in this repression. This autoregulatory mechanism of repression implies that the GR concentration can coordinate repression with excess ligand, regardless of the combinatorial associations of tissue-specific transcription factors. Consequently, the chronic nature of inflammatory conditions involving long-term glucocorticoid administration may lead to constitutive repression of GR gene transcription and thus to glucocorticoid resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Another example of a GR-binding site located a great distance from the transcription start site is the intragenic nGRE recently identified in exon 6 of the GR gene that mediates homologous down-regulation of GR expression24.”
From Corticosteroids (2016) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Glucocorticoids regulate diverse physiological processes, including development, metabolism, homeostasis, inflammation, and responses to both physiological and psychological stresses (1, 2).”
BackgroundSapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 1×
“Clinically, synthetic glucocorticoids are employed for the treatment of numerous inflammatory conditions, including ectopia, dermatitis, allergies and asthma, osteoarthritis, adrenal insufficiency, autoimmune disorders, and organ rejection (3).”
BackgroundSelf-citationSTEROID RECEPTOR REGULATED TRANSCRIPTION OF SPECIFIC GENES AND GENE NETWORKS
Yamamoto, K. R. (1985) · Annual Review of Genetics · doi:10.1146/annurev.ge.19.120185.001233 · Cited by 1,872
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591 · cited 1×
“Glucocorticoids regulate diverse physiological processes, including development, metabolism, homeostasis, inflammation, and responses to both physiological and psychological stresses (1, 2).”
BackgroundGenome-wide analysis of estrogen receptor binding sites
Carroll, J. S., Meyer, C. A., Song, J., Li, W., Geistlinger, T. R., Eeckhoute, J., Brodsky, A. S., Keeton, E. K., Fertuck, K. C., Hall, G. F., et al. (2006) · Nature Genetics · doi:10.1038/ng1901 · Cited by 1,377
Quantitative analysis of chromosome conformation capture assays (3C-qPCR)
Hagège, H., Klous, P., Braem, C., Splinter, E., Dekker, J., Cathala, G., de Laat, W., & Forné, T. (2007) · Nature Protocols · doi:10.1038/nprot.2007.243 · Cited by 720 · cited 1×
“formed with A549 cells as described previously (35), with minor modifi-”
Background
Research works printed but not linked: 1
- 10.1128/mcb.4.3.449-453.1984 · doi:10.1128/mcb.4.3.449-453.1984
Cited by
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
Self-citationGlucocorticoid receptor signaling in health and disease
Kadmiel, M., & Cidlowski, J. A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.003 · Cited by 849
“Examples of genes negatively regulated by GR are β-arrestin 2 [19], osteocalcin [18] and the GR gene, NR3C1 itself [20].”
BackgroundSelf-citationRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Self-citationA General Introduction to Glucocorticoid Biology
Timmermans, S., Souffriau, J., & Libert, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01545 · Cited by 609
Comprehensive Overview of the Structure and Regulation of the Glucocorticoid Receptor
Vandevyver, S., Dejager, L., & Libert, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1010 · Cited by 265
Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds
Sundahl, N., Bridelance, J., Libert, C., De Bosscher, K., & Beck, I. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.001 · Cited by 216
Petta, I., Dejager, L., Ballegeer, M., Lievens, S., Tavernier, J., De Bosscher, K., & Libert, C. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-15 · Cited by 203
Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor
Escoter-Torres, L., Caratti, G., Mechtidou, A., Tuckermann, J. P., Uhlenhaut, N. H., & Vettorazzi, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01859 · Cited by 175
TH17 cells and corticosteroid insensitivity in severe asthma
Xie, Y., Abel, P. W., Casale, T. B., & Tu, Y. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.12.769 · Cited by 152
Why do some asthma patients respond poorly to glucocorticoid therapy?
Henderson, I. L., Caiazzo, E., McSharry, C. P., Guzik, T. J., & Maffia, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105189 · Cited by 139
After 62 years of regulating immunity, dexamethasone meets COVID-19
Cain, D. W., & Cidlowski, J. A. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00421-x · Cited by 123
Self-citationMartinez, G. J., Appleton, M., Kipp, Z. A., Loria, A. S., Min, B., & Hinds, T. D. (2023) · Physiological Reviews · doi:10.1152/physrev.00021.2023 · Cited by 118
Bockmühl, Y., Patchev, A. V., Madejska, A., Hoffmann, A., Sousa, J. C., Sousa, N., Holsboer, F., Almeida, O. F. X., & Spengler, D. (2015) · Epigenetics · doi:10.1080/15592294.2015.1017199 · Cited by 117
Defining the role of glucocorticoids in inflammation
Ronchetti, S., Migliorati, G., Bruscoli, S., & Riccardi, C. (2018) · Clinical Science · doi:10.1042/cs20171505 · Cited by 109
Hua, G., Ganti, K. P., & Chambon, P. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522826113 · Cited by 106
Hua, G., Paulen, L., & Chambon, P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522821113 · Cited by 86
Dominance of the strongest: Inflammatory cytokines versus glucocorticoids
Dejager, L., Vandevyver, S., Πέττα, Ι., & Libert, C. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.006 · Cited by 85
Nicolaides, N. C., Charmandari, E., Chrousos, G. P., & Kino, T. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-71 · Cited by 83
Environmental Stressors and Epigenetic Control of the Hypothalamic-Pituitary-Adrenal Axis
Lee, R. S., & Sawa, A. (2014) · Neuroendocrinology · doi:10.1159/000369585 · Cited by 79
Lesovaya, E. A., Yemelyanov, A. Y., Swart, A. C., Swart, P., Haegeman, G., & Budunova, I. V. (2015) · Oncotarget · doi:10.18632/oncotarget.5078 · Cited by 78
Deng, Q., Riquelme, D., Trinh, L., Low, M. J., Tomić, M., Stojilkovic, S., & Aguilera, G. (2015) · Endocrinology · doi:10.1210/en.2015-1265 · Cited by 77
Meijer, O. C., Buurstede, J. C., & Schaaf, M. J. M. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0625-2 · Cited by 77
Wiley, J. W., Higgins, G. A., & Athey, B. D. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12706 · Cited by 75
Chrousos syndrome: from molecular pathogenesis to therapeutic management
Nicolaides, N. C., & Charmandari, E. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12426 · Cited by 67
Batalha, V. L., Ferreira, D. G., Coelho, J. E., Valadas, J. S., Gomes, R., Temido-Ferreira, M., Shmidt, T., Baqi, Y., Buée, L., Müller, C. E., et al. (2016) · Scientific Reports · doi:10.1038/srep31493 · Cited by 66
Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases
Ana Maria, A., Oscar Andréas, M.-R., & Haider, N. B. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25480 · Cited by 59
Disease- and treatment-associated acquired glucocorticoid resistance
Wilkinson, L., Verhoog, N. J. D., & Louw, A. (2018) · Endocrine Connections · doi:10.1530/ec-18-0421 · Cited by 58
Mostafa, M., Rider, C. F., Shah, S., Traves, S. L., Gordon, P. M. K., Miller‐Larsson, A., Leigh, R., & Newton, R. (2019) · BMC Medical Genomics · doi:10.1186/s12920-018-0467-2 · Cited by 57
Mifsud, K. R., Saunderson, E. A., Spiers, H., Carter, S. D., Trollope, A. F., Mill, J. S., & Reul, J. M. H. M. (2016) · Neuroendocrinology · doi:10.1159/000445875 · Cited by 57
Burris, T. P., de Vera, I. M. S., Côté, I., Flaveny, C. A., Wanninayake, U. S., Chatterjee, A., Walker, J. K., Steinauer, N., Zhang, J., Coons, L. A., et al. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000436 · Cited by 56
Self-citationAndrogenic signaling systems and their role in behavioral evolution
Fuxjager, M. J., & Schuppe, E. R. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.06.004 · Cited by 56
Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies
Clarisse, D., Offner, F. C., & Bosscher, K. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188430 · Cited by 53
Lorén, V., García-Jaraquemada, A., Naves, J. E., Carmona, X., Mañosa, M., Aransay, A. M., Lavín, J. L., Sánchez, I., Cabré, E., Manyé, J., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy171 · Cited by 51
HOS15 is a transcriptional corepressor of NPR1-mediated gene activation of plant immunity
Shen, M., Lim, C. J., Park, J., Kim, J. E., Baek, D., Nam, J., Lee, S. Y., Pardo, J. M., Kim, W., Mackey, D. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016049117 · Cited by 50
GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life
Louw, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01693 · Cited by 46
The long winding road to the safer glucocorticoid receptor (GR) targeting therapies
Lesovaya, E. A., Chudakova, D. A., Baida, G. E., Михайловна, Ж. Е., Игоревич, К. К., Геннадиевна, Я. М., & Budunova, I. V. (2022) · Oncotarget · doi:10.18632/oncotarget.28191 · Cited by 45
PI3K inhibitors protect against glucocorticoid-induced skin atrophy
Agarwal, S., Mirzoeva, S., Readhead, B., Dudley, J. T., & Budunova, I. V. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.055 · Cited by 43
Na, W., Shin, J. Y., Lee, J. Y., Jeong, S., Kim, W., Yune, T. Y., & Ju, B. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17701156 · Cited by 41
NCOR1—a new player on the field of T cell development
Müller, L., Hainberger, D., Stolz, V., & Ellmeier, W. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ri0418-168r · Cited by 41
Cruz‐Topete, D., He, B., Xu, X., & Cidlowski, J. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.725903 · Cited by 41
Self-citationMolecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies
Scheijen, B. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.29 · Cited by 41
A miR‐29a‐driven negative feedback loop regulates peripheral glucocorticoid receptor signaling
Glantschnig, C., Koenen, M., Gil‐Lozano, M., Karbiener, M., Pickrahn, I., Williams‐Dautovich, J., Patel, R., Cummins, C. L., Giroud, M., Hartleben, G., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801385rr · Cited by 40
The effects of microRNAs on glucocorticoid responsiveness
Wang, H., Gou, X., Jiang, T., & Ouyang, J. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2388-4 · Cited by 38
Muscle transcriptome response to ACTH administration in a free-ranging marine mammal
Khudyakov, J. I., Champagne, C. D., Preeyanon, L., Ortiz, R. M., & Crocker, D. E. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00030.2015 · Cited by 38
Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe?
Михайловна, Ж. Е., Lylova, E. S., Grigoreva, D. D., Игоревич, К. К., Osipova, A. V., Kulikov, E. P., Александрович, М. С., Belitsky, G. A., Budunova, I. V., Геннадиевна, Я. М., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179686 · Cited by 37
Spies, L.-M. L., Verhoog, N. J. D., & Louw, A. (2021) · Cells · doi:10.3390/cells10102529 · Cited by 37
An, B. C., Jung, N.-K., Park, C. Y., Oh, I., Choi, Y. D., Park, J., & Lee, S.-W. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0164 · Cited by 36
Potential Dissociative Glucocorticoid Receptor Activity for Protopanaxadiol and Protopanaxatriol
Karra, A. G., Konstantinou, M., Tzortziou, M., Tsialtas, I., Kalousi, F. D., Garagounis, C., Hayes, J. M., & Psarra, A. G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010094 · Cited by 36
Papaioannou, A. Ι., Fouka, E., Ntontsi, P., Stratakos, G. K., & Papiris, S. A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050850 · Cited by 33
Sarusi-Portuguez, A., Grbeša, I., Tal, M., Deitch, R., Raz, D., Kliker, L., Weismann, R., Schwartz, M., Loza, O., Cohen, L., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac488 · Cited by 32
Blubber transcriptome responses to repeated ACTH administration in a marine mammal
Deyarmin, J. S., McCormley, M. C., Champagne, C. D., Stephan, A. P., Busqueta, L. P., Crocker, D. E., Houser, D. S., & Khudyakov, J. I. (2019) · Scientific Reports · doi:10.1038/s41598-019-39089-2 · Cited by 32
Genomic effects of glucocorticoids
Grbeša, I., & Hakim, O. (2016) · PROTOPLASMA · doi:10.1007/s00709-016-1063-y · Cited by 32
Curley, M. K., Milne, L., Smith, S. E., J⊘rgensen, A., Frederiksen, H. W., Hadoke, P. W. F., Potter, P. K., & Smith, L. B. (2018) · The FASEB Journal · doi:10.1096/fj.201800612r · Cited by 31
Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome
Grodzielski, M., & Cidlowski, J. A. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.06.012 · Cited by 31
Self-citationAyyar, V. S., Almon, R. R., DuBois, D. C., Sukumaran, S., Qu, J., & Jusko, W. J. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.03.007 · Cited by 31
A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer
Михайловна, Ж. Е., Lylova, E. S., Savinkova, A. V., Александрович, М. С., Игоревич, К. К., Belitsky, G. A., Геннадиевна, Я. М., & Lesovaya, E. A. (2020) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223420974667 · Cited by 30
Brain-homing CD4 + T cells display glucocorticoid-resistant features in MS
Koetzier, S. C., van Langelaar, J., Blok, K. M., van den Bosch, T. P. P., Wierenga‐Wolf, A. F., Melief, M., Pol, K., Siepman, T. A. M., Verjans, G. M. G. M., Smolders, J., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000894 · Cited by 29
The physiology of stress and the human body’s response to stress
Lee, R. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823039-8.00017-4 · Cited by 28
Xenobiotics and the Glucocorticoid Receptor
Gulliver, L. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.02.003 · Cited by 28
PlexinB1 Promotes Nuclear Translocation of the Glucocorticoid Receptor
Williamson, M. P., Garg, R., & Wells, C. M. (2019) · Cells · doi:10.3390/cells9010003 · Cited by 28
Liang, Y., Zhang, T., Zhao, J., Li, C., Zou, H., Li, F., Zhang, J., & Ren, L. (2021) · Food & Function · doi:10.1039/d1fo01612a · Cited by 27
Williams, S., & Ghosh, C. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.009 · Cited by 26
Calzetta, L., Aiello, M., Frizzelli, A., Bertorelli, G., Rogliani, P., & Chetta, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137132 · Cited by 25
Cox, O., Song, H. Y., Garrison‐Desany, H. M., Gadiwalla, N., Carey, J. L., Menzies, J., & Lee, R. S. (2021) · Epigenetics · doi:10.1080/15592294.2020.1864169 · Cited by 25
Lindsay, E. K., Creswell, J. D., Stern, H. J., Greco, C. M., Dutcher, J. M., Lipitz, S. R., Walsh, C. P., Wright, A. G. C., Brown, K. W., & Marsland, A. L. (2021) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000928 · Cited by 24
Georgatza, D., Gorgogietas, V. A., Kylindri, P., Charalambous, M., Papadopoulou, K. Κ., Hayes, J. M., & Psarra, A. G. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.08.028 · Cited by 24
Lu, W.-H., Chao, H., Lin, P.-Y., Lin, S., Liu, T.-H., Chen, H.-W., & Huang, Y. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01017-2 · Cited by 24
Clarisse, D., Preković, S., Vlummens, P., Staessens, E., Wesemael, K. V., Thommis, J., Fijałkowska, D., Acke, G., Zwart, W. T., Beck, I. M. E., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04900-x · Cited by 22
Endothelial glucocorticoid receptor promoter methylation according to dexamethasone sensitivity
Mata‐Greenwood, E., Jackson, P. N., Pearce, W. J., & Zhang, L. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0124 · Cited by 22
Zheng, G., Pang, S., Wang, J., Wang, F., Wang, Q., Yang, L., Ji, M., Xie, D., Zhu, S., Chen, Y., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107137 · Cited by 21
Phenotypic variation reveals sites of evolutionary constraint in the androgenic signaling pathway
Schuppe, E. R., & Fuxjager, M. J. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.06.002 · Cited by 20
Kassi, E. N., Ansari, N. N., Spilioti, E., Kalotychou, V., Apostolou, P. E., Moutsatsou, P., & Papavassiliou, A. G. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2281-3 · Cited by 19
Novel role for receptor dimerization in post-translational processing and turnover of the GRα
Wilkinson, L., Verhoog, N. J. D., & Louw, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-32440-z · Cited by 19
Rantalainen, M., Bjerrum, J. T., Olsen, J., Nielsen, O. H., & Wang, Y. (2014) · Journal of Proteome Research · doi:10.1021/pr500699h · Cited by 18
Carceller-Zazo, E., Sevilla, L. M., Pons-Alonso, O., Chiner‐Oms, Á., Amazit, L., Vu, T. A., Vitellius, G., Viengchareun, S., Comas, I., Jaszczyszyn, Y., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202201199rr · Cited by 18
Gene expression changes in the brain of a Cushing's syndrome mouse model
Amaya, J. M., Viho, E. M. G., Sips, H. C. M., Lalai, R. A., Sahut‐Barnola, I., Dumontet, T., Montanier, N., Pereira, A. M., Martinez, A., & Meijer, O. C. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13125 · Cited by 17
Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies
Clarisse, D., Thommis, J., Wesemael, K. V., Houtman, R., Ratman, D., Tavernier, J. H., Offner, F. C., Beck, I. M. E., & Bosscher, K. D. (2017) · Oncotarget · doi:10.18632/oncotarget.22764 · Cited by 17
Boswellic acids and their derivatives as potent regulators of glucocorticoid receptor actions
Karra, A. G., Tziortziou, M., Kylindri, P., Γεωργατζά, Δ., Gorgogietas, V. A., Makiou, A.-S., Krokida, A., Tsialtas, I., Kalousi, F. D., Papadopoulos, G. E., et al. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108656 · Cited by 17
Introduction to Epigenetics in Psychiatry
Lee, R. S., & Avramopoulos, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417114-5.00001-2 · Cited by 16
Milara, J., Morell, A., Roger, I., Montero, P., & Cortijo, J. (2023) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2023.2255124 · Cited by 16
Modulation of the circadian clock by glucocorticoid receptor isoforms in the H295R cell line
Nagy, Z., Márta, A., Butz, H., Likó, I., Rácz, K., & Patócs, A. (2016) · Steroids · doi:10.1016/j.steroids.2016.10.002 · Cited by 16
The glucocorticoid receptor is affected by its target ZBTB16 in a dissociated manner
Galuh, S., Faught, E. L., Klaassen, I., Koorneef, L. L., Brinks, J., van Dijk, E. H. C., Elewaut, D. S., Schlingemann, R. O., Schaaf, M. J. M., Boon, C. J. F., et al. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0283 · Cited by 15
RNA binding by the glucocorticoid receptor attenuates dexamethasone-induced gene activation
Lammer, N. C., Ashraf, H. M., Ugay, D. A., Spencer, S. L., Allen, M. A., Batey, R., & Wuttke, D. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-35549-y · Cited by 14
Manzoni, D., Catallo, R., Chebel, A., Baseggio, L., Michallet, A., Roualdes, O., Magaud, J., Salles, G. A., & Ffrench, M. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.05.003 · Cited by 14
Kadhim, H. J., Kang, S. W., & Kuenzel, W. J. (2021) · Stress · doi:10.1080/10253890.2021.1929163 · Cited by 14
Impact of circadian time of dosing on cardiomyocyte-autonomous effects of glucocorticoids
Wintzinger, M., Panta, M., Miz, K., Prabakaran, A. D., Durumutla, H. B., Sargent, M. A., Peek, C. B., Bass, J. T., Molkentin, J. D., & Quattrocelli, M. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101528 · Cited by 13
Koning, A.-S. C. A. M., Habets, P. C., Bogaards, M., Kroon, J., van Santen, H. M., de Bont, J. M., & Meijer, O. C. (2022) · Endocrine Connections · doi:10.1530/ec-21-0425 · Cited by 13
Zhou, L., Roth, M., Papakonstantinou, E., Tamm, M., & Stolz, D. (2024) · Respiratory Research · doi:10.1186/s12931-024-02769-3 · Cited by 13
Enhancer RNA Expression in Response to Glucocorticoid Treatment in Murine Macrophages
Greulich, F., Bielefeld, K. A., Scheundel, R., Mechtidou, A., Strickland, B. A., & Uhlenhaut, N. H. (2021) · Cells · doi:10.3390/cells11010028 · Cited by 12
Lesovaya, E. A., Savinkova, A. V., Morozova, O. V., Lylova, E. S., Михайловна, Ж. Е., Kulikov, E. P., Игоревич, К. К., Kłopot, A., Baida, G. E., Геннадиевна, Я. М., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-1111 · Cited by 11
Zielińska, K. A., Cauwer, L. D., Knoops, S., der Molen, K. V., Sneyers, A., Thommis, J., de Souza, J. B., Opdenakker, G., Bosscher, K. D., & den Steen, P. E. V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01199 · Cited by 11
Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma
Ghiciuc, C. M., Vicovan, A. G., Stafie, C. S., Antoniu, S. A., & Postolache, P. A. (2021) · Marine Drugs · doi:10.3390/md19110586 · Cited by 11
Dhaibar, H. A., Carroll, N., Amatya, S., Kamberov, L., Khanna, P., Orr, A. W., Bailey, S. R., Oakley, R. H., Cidlowski, J. A., & Cruz‐Topete, D. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.015868 · Cited by 11
Self-citationExpression of glucocorticoid receptor (GR) and clinical significance in adrenocortical carcinoma
Wu, K., Liu, Z., Liang, J., Zhang, F., Zhang, F., Wang, Y., Lia, T., Liu, S., Zhu, Y., & Li, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.903824 · Cited by 9
Gallucci, G., Díaz, A., Fernández, R. D. V., Bongiovanni, B., Imhoff, M., Massa, E., Santucci, N. E., Bértola, D., Lioi, S., Bay, M. L., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120614 · Cited by 9
Brulefert, A., Jan, S. L., Plée, J., Durlach, A., Bernard, P., Antonicelli, F. D., & Trussardi‐Régnier, A. (2017) · Experimental Dermatology · doi:10.1111/exd.13444 · Cited by 9
Wang, Y., Qin, J., Dong, L., He, C., Zhang, D., Wu, X., Li, T., Yue, H., Mu, L., Wang, Q., et al. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.09.002 · Cited by 8
Epigenetic and transcriptional regulation of CCL17 production by glucocorticoids in arthritis
Lupancu, T. J., Lee, M.-C., Eivazitork, M., Hor, C., Fleetwood, A. J., Cook, A. D., Olshansky, M., Turner, S. J., de Steiger, R. N., Lim, K. K. T., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108079 · Cited by 7
CD200/CD200 receptor axis in psoriasis vulgaris
Ismail, A. A., Donia, H. M., Ghatesh, H. M., & Farid, C. I. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230621 · Cited by 7
Antoniassi, J. Q., Fochi, R. A., Góes, R. M., Vilamaior, P. S. L., & Taboga, S. R. (2017) · International Journal of Experimental Pathology · doi:10.1111/iep.12232 · Cited by 6
Metadata
- Authors
- Ramamoorthy, S., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2013-05-01
- Volume
- 33
- Issue
- 9
- Pages
- 1711-1722
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3624172
- OpenAlex
- W2020185368
- Cited by
- 146
- References
- 42
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 2 · 2023: 14 · 2022: 11 · 2021: 17 · 2020: 11 · 2019: 16 · 2018: 12 · 2017: 8 · 2016: 15 · 2015: 17 · 2014: 7 · 2013: 4
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- glucocorticoid receptor, glucocorticoid resistance, gene repression, NCOR1, HDAC3, long-range chromatin interactions, transcription start sites, exon 6, transcriptional autoregulation, chronic inflammation
- MeSH terms
- Histone Deacetylase 3, Animals, Cell Line, Chromatin, Drug Resistance, Exons, Glucocorticoids, Histone Deacetylases, Humans, Ligands, Male, Mice, Inbred C57BL, Receptors, Glucocorticoid, Transcriptional Activation, Down-Regulation, Response Elements, Mice, Rats, Nuclear Receptor Co-Repressor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.